Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN) shares gapped up before the market opened on Tuesday . The stock had previously closed at $21.82, but opened at $22.99. Anbio Biotechnology shares last traded at $21.41, with a volume of 3,453 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Anbio Biotechnology Trading Down 2.6%

Anbio Biotechnology (NASDAQ:NNNN) last issued its earnings results on Tuesday, December 30th. The company reported $0.04 EPS for the quarter. The company had revenue of $2.29 million during the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.